Cargando…

In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl

BACKGROUND: Hyperlipidemia, a metabolic disorder of lipids, is a well known risk factor of cardiovascular events and metabolic syndrome. In this study, the in vivo lipid-lowering activity of the triterpene (Methyl-3β-hydroxylanosta-9,24-dien-21-oate), isolated from the stem bark of Protorhus longifo...

Descripción completa

Detalles Bibliográficos
Autores principales: Machaba, Kgothatso E, Cobongela, Sinazo ZZ, Mosa, Rebamang A, Oladipupo, Lawal A, Djarova, Trayana G, Opoku, Andy R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246574/
https://www.ncbi.nlm.nih.gov/pubmed/25127687
http://dx.doi.org/10.1186/1476-511X-13-131
_version_ 1782346542161592320
author Machaba, Kgothatso E
Cobongela, Sinazo ZZ
Mosa, Rebamang A
Oladipupo, Lawal A
Djarova, Trayana G
Opoku, Andy R
author_facet Machaba, Kgothatso E
Cobongela, Sinazo ZZ
Mosa, Rebamang A
Oladipupo, Lawal A
Djarova, Trayana G
Opoku, Andy R
author_sort Machaba, Kgothatso E
collection PubMed
description BACKGROUND: Hyperlipidemia, a metabolic disorder of lipids, is a well known risk factor of cardiovascular events and metabolic syndrome. In this study, the in vivo lipid-lowering activity of the triterpene (Methyl-3β-hydroxylanosta-9,24-dien-21-oate), isolated from the stem bark of Protorhus longifolia, in high fat diet (HFD)-induced hyperlipidemic rats was investigated. METHODS: Structure of the isolated compound was established and confirmed based on spectral (NMR, HRMS, IR) data analysis. Rats were divided into two groups; normal group (fed the normal commercial rats’ chow) and the HFD group. After 21 days of experimental period on their respective diets, the HFD rats were sub-divided into 4 groups of six rats per group. Two of the HFD groups were orally treated with the triterpene (100 and 200 mg/kg body weight) for 15 days. At the end of the experimental periods, the rats were sacrificed and blood samples were collected for biochemical assays. RESULTS: The results show that there were significant increases in total serum cholesterol (TC, 15.72 mmol/L) and low-density lipoprotein cholesterol (LDL-c, 7.41 mmol/L) with a reduction in high-density lipoprotein cholesterol (HDL-c, 14.75 mmol/L) in HFD-induced hyperlipidemic rats after 21 days. Oral administration of the triterpene (100 mg/kg.bw and 200 mg/kg.bw) for a period of 15 days resulted in significant lowering of the levels of TC (7.51 mmol/L) and LDL-c (4.46 mmol/L) with an increase in HDL-c (47.3 mmol/L) in HFD-induced hyperlipidemic rats. Significant decrease in atherogenic index and coronary risk index by the triterpene was observed in HFD-induced hyperlipidemic rats. CONCLUSIONS: The triterpene could effectively reduce or control the amount of serum cholesterol and LDL. It is apparent that the compound could contribute to new formulation with significant hypolipidemic effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-511X-13-131) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4246574
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42465742014-11-29 In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl Machaba, Kgothatso E Cobongela, Sinazo ZZ Mosa, Rebamang A Oladipupo, Lawal A Djarova, Trayana G Opoku, Andy R Lipids Health Dis Research BACKGROUND: Hyperlipidemia, a metabolic disorder of lipids, is a well known risk factor of cardiovascular events and metabolic syndrome. In this study, the in vivo lipid-lowering activity of the triterpene (Methyl-3β-hydroxylanosta-9,24-dien-21-oate), isolated from the stem bark of Protorhus longifolia, in high fat diet (HFD)-induced hyperlipidemic rats was investigated. METHODS: Structure of the isolated compound was established and confirmed based on spectral (NMR, HRMS, IR) data analysis. Rats were divided into two groups; normal group (fed the normal commercial rats’ chow) and the HFD group. After 21 days of experimental period on their respective diets, the HFD rats were sub-divided into 4 groups of six rats per group. Two of the HFD groups were orally treated with the triterpene (100 and 200 mg/kg body weight) for 15 days. At the end of the experimental periods, the rats were sacrificed and blood samples were collected for biochemical assays. RESULTS: The results show that there were significant increases in total serum cholesterol (TC, 15.72 mmol/L) and low-density lipoprotein cholesterol (LDL-c, 7.41 mmol/L) with a reduction in high-density lipoprotein cholesterol (HDL-c, 14.75 mmol/L) in HFD-induced hyperlipidemic rats after 21 days. Oral administration of the triterpene (100 mg/kg.bw and 200 mg/kg.bw) for a period of 15 days resulted in significant lowering of the levels of TC (7.51 mmol/L) and LDL-c (4.46 mmol/L) with an increase in HDL-c (47.3 mmol/L) in HFD-induced hyperlipidemic rats. Significant decrease in atherogenic index and coronary risk index by the triterpene was observed in HFD-induced hyperlipidemic rats. CONCLUSIONS: The triterpene could effectively reduce or control the amount of serum cholesterol and LDL. It is apparent that the compound could contribute to new formulation with significant hypolipidemic effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-511X-13-131) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-15 /pmc/articles/PMC4246574/ /pubmed/25127687 http://dx.doi.org/10.1186/1476-511X-13-131 Text en © Machaba et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Machaba, Kgothatso E
Cobongela, Sinazo ZZ
Mosa, Rebamang A
Oladipupo, Lawal A
Djarova, Trayana G
Opoku, Andy R
In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl
title In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl
title_full In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl
title_fullStr In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl
title_full_unstemmed In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl
title_short In vivo anti-hyperlipidemic activity of the triterpene from the stem bark of Protorhus longifolia (Benrh) Engl
title_sort in vivo anti-hyperlipidemic activity of the triterpene from the stem bark of protorhus longifolia (benrh) engl
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246574/
https://www.ncbi.nlm.nih.gov/pubmed/25127687
http://dx.doi.org/10.1186/1476-511X-13-131
work_keys_str_mv AT machabakgothatsoe invivoantihyperlipidemicactivityofthetriterpenefromthestembarkofprotorhuslongifoliabenrhengl
AT cobongelasinazozz invivoantihyperlipidemicactivityofthetriterpenefromthestembarkofprotorhuslongifoliabenrhengl
AT mosarebamanga invivoantihyperlipidemicactivityofthetriterpenefromthestembarkofprotorhuslongifoliabenrhengl
AT oladipupolawala invivoantihyperlipidemicactivityofthetriterpenefromthestembarkofprotorhuslongifoliabenrhengl
AT djarovatrayanag invivoantihyperlipidemicactivityofthetriterpenefromthestembarkofprotorhuslongifoliabenrhengl
AT opokuandyr invivoantihyperlipidemicactivityofthetriterpenefromthestembarkofprotorhuslongifoliabenrhengl